Literature DB >> 1233258

Disposition of beta-methyldigoxin in man.

N Rietbrock, U Abshagen, K Bergmann, H Rennekamp.   

Abstract

The time course of radioactivity in plasma and the excretion in urine and faeces over 7 days were determined in 12 healthy subjects after single oral and intravenous doses of a solution of 3H-beta-methyldigoxin. 62.2 +/- 2.1 and 29.0 +/- 5.2 per cent of the dose were excreted in urine and faeces, respectively, within 7 days of intravenous administration, compared with 55.2 +/- 2.8 and 28.6 +/- 5.7 per cent after oral administration. This indicates almost complete absorption of the glycoside when given in solution. 12 hours after its administration a pseudo-distribution equilibrium was reached and the average half life of tritiated compounds was 1.3 days. By 48 - 96 hours after treatment the average half life was 2.8 days. O-demethylation was revealed as the main metabolic degradation step in man. The rate of Demethylation was higher after oral than i.v. administration. Thus, only 31% of the radioactivity excreted in the urine consisted of unchanged beta-methyl-digoxin after oral administration compared to 51% after i.v. dosing. Only traces of bis- and monoglycosides were excreted in urine, but there were considerable amounts in faeces, where they accounted for more than 35% of the total excretion. Up to 40% of the radioactivity in plasma and urine consisted of polar conjugates during the first 12 hours after administration of beta-methyldigoxin. The mono- and bisglycosides were identified as the main products of conjugation. During the 7 days approximately 15% of the administered dose was metabolized by splitting off glycosidic bonds and conjugation to polar compounds.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1233258     DOI: 10.1007/bf00614005

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  23 in total

1.  [CONJUGATION OF CARDENOLIDE GENINS WITH SULFURIC ACID OR GLUCURONIC ACID].

Authors:  I HERRMANN; K REPKE
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1964-06-22

2.  [Distribution, excretion and metabolism of digitoxin in rats].

Authors:  K REPKE
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1958

3.  Metabolism of digoxigenin, digoxigeninmonodigitoxoside and digoxigeninbisdigitoxoside in rats.

Authors:  U Abshagen; N Rietbrock
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

4.  Cleavage of glycosidic bonds of digoxin and derivatives as function of pH and time.

Authors:  J Kuhlmann; U Abshagen; N Rietbrock
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

5.  Demethylation and cleavage of glycosidic bonds of 4'''-methyldigoxin in man.

Authors:  N Rietbrock; C Rennekamp; H Rennekamp; K von Bergmann; U Abshagen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

6.  Pharmacokinetics of digoxin and its 4'''-acetyl- and methylderivates in the rat.

Authors:  N Rietbrock; U Abshagen; K von Bergmann; H Kewitz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

7.  Pharmacokinetics and metabolism of digoxigenin-mono-digitoxoside in man.

Authors:  J Kuhlmann; U Abshagen; N Rietbrock
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

8.  [Metabolism and pharmacokinetics of lanatosides in man].

Authors:  N Rietbrock; U Abshagen
Journal:  Dtsch Med Wochenschr       Date:  1973-01-19       Impact factor: 0.628

9.  [Comulative behavior of various cardiac glycosides in anuria].

Authors:  P Kramer; J Horenkamp; B Willms; F Scheler
Journal:  Dtsch Med Wochenschr       Date:  1970-02-27       Impact factor: 0.628

10.  [Behavior of cardiac glycosides in human organism. A review based on the example of digoxin and lanatoside C].

Authors:  R Blankart
Journal:  Ther Umsch       Date:  1971-04
View more
  4 in total

1.  Bioavailability and pharmacokinetics of beta-methyldigoxin after multiple oral and intravenous doses.

Authors:  N Rietbrock; J Guggenmos; J Kuhlmann; U Hess
Journal:  Eur J Clin Pharmacol       Date:  1976-03-22       Impact factor: 2.953

Review 2.  Pharmacologically active metabolites of drugs and other foreign compounds. Clinical, pharmacological, therapeutic and toxicological considerations.

Authors:  D E Drayer
Journal:  Drugs       Date:  1982-12       Impact factor: 9.546

Review 3.  Pharmacologically active drug metabolites: therapeutic and toxic activities, plasma and urine data in man, accumulation in renal failure.

Authors:  D E Drayer
Journal:  Clin Pharmacokinet       Date:  1976 Nov-Dec       Impact factor: 6.447

4.  Comparative pharmacokinetics and pharmacodynamics of cardiac glycosides.

Authors:  A W Kelman; D J Sumner; M Lonsdale; J R Lawrence; B Whiting
Journal:  Br J Clin Pharmacol       Date:  1980-08       Impact factor: 4.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.